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Abstract
Salivary proteins injected by blood feeding arthropods into their hosts evoke a saliva-specific humoral response which can
be useful to evaluate exposure to bites of disease vectors. However, saliva of hematophagous arthropods is a complex
cocktail of bioactive factors and its use in immunoassays can be misleading because of potential cross-reactivity to other
antigens. Toward the development of a serological marker of exposure to Afrotropical malaria vectors we expressed the
Anopheles gambiae gSG6, a small anopheline-specific salivary protein, and we measured the anti-gSG6 IgG response in
individuals from a malaria hyperendemic area of Burkina Faso, West Africa. The gSG6 protein was immunogenic and anti-
gSG6 IgG levels and/or prevalence increased in exposed individuals during the malaria transmission/rainy season. Moreover,
this response dropped during the intervening low transmission/dry season, suggesting it is sensitive enough to detect
variation in vector density. Members of the Fulani ethnic group showed higher anti-gSG6 IgG response as compared to
Mossi, a result consistent with the stronger immune reactivity reported in this group. Remarkably, anti-gSG6 IgG levels
among responders were high in children and gradually declined with age. This unusual pattern, opposite to the one
observed with Plasmodium antigens, is compatible with a progressive desensitization to mosquito saliva and may be linked
to the continued exposure to bites of anopheline mosquitoes. Overall, the humoral anti-gSG6 IgG response appears a
reliable serological indicator of exposure to bites of the main African malaria vectors (An. gambiae, Anopheles arabiensis and,
possibly, Anopheles funestus) and it may be exploited for malaria epidemiological studies, development of risk maps and
evaluation of anti-vector measures. In addition, the gSG6 protein may represent a powerful model system to get a deeper
understanding of molecular and cellular mechanisms underlying the immune tolerance and progressive desensitization to
insect salivary allergens.
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Introduction
It is well known that blood sucking arthropods salivate injecting
into their hosts, while feeding, a complex cocktail of bioactive
factors of essential importance for the successful acquisition of the
blood meal [1]. The main role of these components is to
antagonize the physiological responses of the host to tissue injury,
namely hemostasis, inflammation and immunity [2,3]. However,
independently from their biochemical properties, these factors also
elicit into the host a humoral response and, hence, circulating anti-
salivary proteins antibodies can be detected in the sera of
individuals repeatedly bitten by arthropods. This anti-saliva
antibody response may represent a useful tool to evaluate host
exposure to arthropod vectors of diseases such as ticks [4], sand
flies [5], triatomines [6], tsetse flies [7,8] and mosquitoes [9–13].
So far, large-scale epidemiological analyses based on the anti-
saliva immune response, have been hindered by the difficulty of
obtaining large amounts of saliva or salivary extracts (which is
tedious, difficult to standardize and poorly reproducible) and,
more importantly, by the complex nature of blood sucking
arthropod saliva, that may give rise to potentially misleading cross-
reactivity to other antigens. Transcriptome and proteome analyses
in the last 5–10 years highlighted that the salivary repertoires of
blood-feeding insects consist both of proteins that are widely
shared between insect families and of proteins that are family-,
genus- and even species-specific [3], most probably as result of the
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convergent evolutionary nature of hematophagy and of the
unusually fast evolutionary rate of salivary proteins [14–16].
Comparative analysis of sialotranscriptomes from different Culic-
idae family members allowed for the identification of a large group
of Anopheles-specific proteins, i.e. not found in Culex or Aedes
mosquitoes, and viceversa [17–19]. These proteins, if immuno-
genic, may represent ideal candidates for the development of
serological markers of exposure to anopheline mosquitoes.
We focused the attention on one of these Anopheles-specific
proteins, which we previously identified and named as gambiae
Salivary Gland protein 6 (gSG6, GI: 13537666) [20]. This is a
small polypeptide (,10 kDa) specifically expressed in adult female
salivary glands, relatively abundant in saliva and with no
significant similarity to any other known protein. The precise
function of gSG6 is still undetermined, although its depletion from
mosquito saliva by RNAi affects probing time and blood feeding
ability [21]. In this study we report the purification of the
Escherichia coli-expressed gSG6 and its use for a large scale
epidemiological analysis on sera of individuals from a malaria
hyperendemic area of Burkina Faso, West Africa.
Results
A Pichia pastoris-expressed version of the An. gambiae gSG6 [21]
was previously used to measure the anti-gSG6 IgG response in a
small group of sixteen Senegalese children living in a malaria
endemic area. This initial test provided encouraging preliminary
information on the immunogenicity of the protein [22]; however,
the Pichia-expressed gSG6 generated a relatively high background
in control sera (i.e. sera from individuals not exposed to Anopheles
bites) even though it was apparently pure and not glycosilated [21]
(B.A., unpublished observations). Nevertheless, the promising
results obtained with a gSG6-based peptide [22,23] prompted us
to express the protein in E. coli. The recombinant protein has a
predicted molecular mass of ,12.4 kDa (108 aa) and carries an
additional 21 aminoacids at the N-terminus (His-tag and thrombin
site). Purification was achieved by His-Trap affinity chromatog-
raphy in denaturing conditions, followed by refolding of the
protein and by anion-exchange chromatography (Figure 1, panels
A–C). The purity and correct refolding of the recombinant gSG6
was confirmed by reverse-phase high-pressure liquid chromatog-
raphy (RP-HPLC) and mass spectrometry (MS) (Figure 1, panels
D–E). MS analysis yielded a major peak corresponding to a mass
of 12244.4, which fits very well with the mass expected for the
recombinant gSG6 lacking the starting Met and with the ten Cys
residues involved in disulfide bridges (12243.6).
Anti-gSG6 IgG were measured by Enzyme-Linked Immuno-
Sorbent Assay (ELISA) in 1752 human sera collected in two
villages of a rural malaria hyperendemic area of Burkina Faso
during three consecutive years, at the beginning and at the end of
each high transmission rainy season (August and October ‘94, ‘95
and ‘96), and during one of the intervening low transmission dry
season (March ‘95). Sera from 42 Europeans non-exposed to bites
of anopheline mosquitoes were used as controls. It is worth
pointing out two aspects with relevant epidemiological implica-
tions. First, the two villages under study are inhabited by ethnic
groups with different immune reactivity and susceptibility to
Plasmodium falciparum malaria [24]: the Fulani living in Barkoun-
douba and the Mossi in Barkoumbilen. Second, insecticide-treated
curtains (ITC) were distributed and applied in the two villages just
before the 1996 high transmission season (June) [25]. The villages
were under entomological monitoring during the study periods
and, as previously reported, P. falciparum inoculation rates were
comparable in Barkoundouba and Barkoumbilen [25]. The
number of Anopheles/person/night, as measured by the indoor
pyrethrum spray catch method, appeared higher in Barkoundouba
as compared to Barkoumbilen; however, only in August ’94,
March ’95 and July-August ’96 this difference was statistically
significant (Figure 2). The decreased vector density observed in
July-October ‘95, in comparison to August-October ‘94, was most
likely a consequence of the lower rainfall [24]. Overall a clear drop
in Anopheles density was evident both during the dry season (March
’95) and after application of ITC (July-August ’96, September-
October ’96).
gSG6 immunogenicity
Anti-gSG6 IgG prevalences and levels were significantly higher
in the sera of individuals exposed to Anopheles bites (Burkinabe´) as
compared to non-exposed controls (European). As an example the
OD values among responders (i.e. individuals with OD values
above the cut-off) from the August ‘94 survey and in control
subjects are reported in Figure 3. Very similar patterns and
identical highly statistical differences (p,0.0001) were also found
when the remaining six surveys and/or all the individuals, rather
than just the responders, were analyzed (not shown). These
observations show that the An. gambiae gSG6 is immunogenic,
Figure 1. Expression and purification of the An. gambiae gSG6
salivary protein. Recombinant gSG6 was expressed in E. coli
Bl21(DE3)RIL cells. (A) SDS-PAGE analysis of protein fractions from
uninduced (Un) and induced cells (Ind). (B) SDS-PAGE analysis of
pooled protein fractions obtained after His-Trap affinity chromatogra-
phy (AC) under denaturing conditions. (C) Fractions containing purified
gSG6 after anion exchange chromatography (IEC) were pooled and
analyzed by SDS-PAGE. (D) Homogeneity of the purified protein was
confirmed by Reverse Phase HPLC. The first peak is artifactual and the
second one corresponds to the gSG6 recombinant protein. (E) Mass
Spectrometry, the mass corresponding to the recombinant gSG6 is
indicated. MW, Molecular Weight Markers.
doi:10.1371/journal.pone.0017980.g001
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evokes in exposed individuals an IgG antibody response and,
importantly, that no appreciable cross-reactivity is detectable in
sera of individuals non-exposed to bites of anopheline mosquitoes.
Seasonal variation of the anti-gSG6 IgG response
When the anti-gSG6 IgG response was compared in the seven
different surveys a seasonal variation was readily observed. As a
general pattern the anti-gSG6 IgG response increased, or persisted
at a high stationary level, during the transmission/rainy season
(August to October), when there is a continued exposure to bites of
anopheline mosquitoes. This trend appeared already evident by
plotting the OD levels of responders in the different surveys
(Figure 4A), and it was even more pronounced by looking at the
prevalence (Figure 4B). The frequency of responders increased
significantly from the beginning (August) to the end (October) of
the transmission season both in the 1994 and 1995 surveys
(p#0.01), whereas no significant increase was found during 1996,
perhaps because of the lower indoor mosquito density due to the
ITC applied in June ‘96. Remarkably, both anti-gSG6 antibody
levels and prevalence dropped significantly during the dry season
(March ‘95) to increase again during the following transmission/
rainy periods (August-October ’95), and these changes were highly
significant (Figure 4, p,0.01). Overall, the pattern of seasonal
variation parallels the exposure to anopheline vectors and malaria
Figure 2. Anopheles density in the villages of Barkoundouba
and Barkoumbilen. The density is expressed as the mean of
anopheline mosquitoes (An. gambiae sensu lato + An. funestus) per
person per night. Whiskers denote the 95% Confidence Interval (CI). The
number of catches (n) in Barkoundouba and Barkoumbilen in the
different surveys were, respectively: August ’94 (n = 12, n = 12),
September-October ’94 (n = 24, n = 24), March ’95 (n = 12, n = 12), July-
August ’95 (n = 26, n = 28), September-October ’95 (n = 36, n = 36), July-
August ’96 (n = 26, n = 28), September-October ’95 (n = 23, n = 22).
P value was determined according to Student’s two-tailed t-test
(**, 0.001,p,0.01).
doi:10.1371/journal.pone.0017980.g002
Figure 3. Anti-gSG6 IgG levels in exposed individuals and in
non-exposed controls. Box plot of OD values in European non
exposed controls and in responders from the August ’94 survey.
Number of individuals included in the analysis (n), average age in years
695% CI were as follows: Europeans, n = 42 (33.466.1); August ‘94,
n = 197 (15.062.0). Box plots display the median OD value, 25th and 75th
percentile. Whiskers represent 5–95 percentile and dots the outliers. P
value was determined according to Mann-Whitney test.
doi:10.1371/journal.pone.0017980.g003
Figure 4. Seasonal variation of the anti-gSG6 IgG response. (A)
Box plot of OD values in the responders from the different surveys.
Number of individuals, average age 695% CI, box plots and whiskers as
in Figure 3. August ’94, n = 197 (15.062.0); October ’94, n = 135
(14.862.5); March ’95, n = 91 (15.063.0); August ’95, n = 238
(14.261.8); October ’95, n = 233 (15.161.9); August ’96, n = 83
(13.162.4); October ’96, n = 171 (16.462.3). P value was determined
according to Kruskal-Wallis test. Pairwise comparisons refer to Dunn’s
multiple comparison test (**, 0.001,p,0.01; ***, p,0.001). (B)
Seasonal variation of seroprevalence of anti-gSG6 IgG. The frequency
of responders during the seven different surveys is reported. Whiskers
denote the 95% CI. August ’94, n = 336 (19.061.9); October ’94, n = 191
(16.262.3); March ’95, n = 163 (17.162.4); August ’95, n = 370
(15.861.5); October ’95, n = 316 (16.561.7); August ’96, n = 129
(18.262.8); October ’96, n = 247 (19.362.3). P values were determined
by Yates-corrected chi square test (**, 0.001,p,0.01; ***, p,0.001).
doi:10.1371/journal.pone.0017980.g004
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transmission. Moreover, the drop during the intervening dry
season implies that the anti-gSG6 IgG response is not long-lasting
and tends to decrease after a few months of lower or absent
exposure.
Anti-gSG6 IgG response in the Mossi and Fulani ethnic
groups
When the data shown in Figure 4 were plotted stratifying for the
two different ethnic groups the Fulani revealed a constantly higher
anti-gSG6 IgG response (Figure 5A), and this difference was
statistically significant in most surveys (August ’94, March ’95,
October ’95 and October ’96; Mann-Withney, 0.0408.p.2e-4).
Similarly, the Fulani always exhibited a higher prevalence
(Figure 5B), which also was significant in most cases (August ’94,
March ’95, August ’95 and October ’96; Yates’ chi-square,
0.008.p.6e-6). This higher anti-gSG6 humoral response was not
unexpected because, as previously reported, Fulani display a
higher immune reactivity as compared to the sympatric ethnic
groups Mossi and Rimaibe´ and are more resistant to malaria
infection [24]. A detailed account of the parasitological status of
the population under study has been described elsewhere [24,25],
however, we shortly summarize here Plasmodium parasite rates in
the Mossi and Fulani ethnic groups during the seven surveys
(Figure 5C). Remarkably, the seasonal variation of the anti-gSG6
IgG response was less pronounced in the Fulani, although the
trend appeared essentially the same in both ethnic groups.
Comparison of both anti-gSG6 IgG levels and prevalence between
the dry period (March ’95) and the previous or following
transmission/rainy seasons yielded a significant difference only
in the Mossi, never in the Fulani (Figure 5A and 5B). Finally, it is
worth noting that the prevalence significantly increased in the
Mossi from the beginning to the end of the transmission/rainy
season both in the 1994 and in the 1995 surveys (Yates’ chi-square,
p = 0.0016 and p = 0.0023 respectively); on the contrary, no
difference in the prevalence was observed between August (0.57)
and October (0.53) following the set-up of ITC in June ‘96
(Figure 5B). This different trend appears fully compatible with a
reduced indoor vector density and the consequential expected
reduced exposure to Anopheles bites.
Pattern of the anti-gSG6 IgG response according to age
It is widely known that in endemic areas the humoral response
to Plasmodium falciparum antigens develops gradually, being lower in
children under five years of age and progressively increasing to
reach the highest level in adults. This age-related profile of
increased seroprevalence and antibody levels against different P.
falciparum antigens (CSP, TRAP, MSA-1, Pf155, Pf332) has also
been reported for the same individuals analyzed in this study
[24,26]. When the anti-gSG6 IgG response was stratified into five
different age groups, both the Mossi and the Fulani exhibited an
age-dependent decrease, rather than increase, in the humoral
response. This was readily evident for the August ‘94 sample when
the anti-gSG6 IgG levels were plotted according to the different
age-groups (Figure 6A) and similar patterns were observed for the
other surveys (not shown). Actually, in all cases the median OD
values among the responders was higher in children (1–10 years)
than in adults (.20 years) and in most cases (8/14) the difference
Figure 5. Anti-gSG6 humoral response in the ethnic groups
Mossi and Fulani. (A) Box plot of OD values among responders in the
seven different surveys (Mossi, empty boxes; Fulani, grey boxes). The
number of Mossi (M), Fulani (F) and the average age 695% CI were as
follows: August ’94 M=104 (16.163.1), F = 93 (13.862.6); October ’94
M=92 (13.462.8), F = 43 (17.765.2); March ’95 M=46 (18.764.9), F = 45
(11.263.1); August ’95 M=146 (16.162.8), F = 92 (11.061.6); October
’95 M=127 (12.862.2), F = 106 (17.863.1); August ’96 M=41 (13.663.6),
F = 42 (12.763.2); October ’96 M=56 (14.563.2), F = 115 (17.363.1). Box
plots, whiskers and p values as in Figure 4A. (B) Prevalence of
antibodies to gSG6 in Mossi (empty columns) and Fulani (grey columns)
in the seven different surveys. Whiskers and p values as in Figure 4B.
The number of Mossi (M), Fulani (F) and the average age 695% CI were
as follows: August ’94 M=205 (19.862.6), F = 131 (17.762.9); October
’94 M=134 (14.062.4), F = 57 (21.565.0); March ’95 M=98 (17.463.1),
F = 65 (16.763.7); August ’95 M=253 (17.562.1), F = 117 (12.061.5);
October ’95 M=175 (13.762.0), F = 141 (19.962.9); August ’96 M=72
(18.463.8), F = 57 (17.964.1); October ’96 M=105 (18.363.3), F = 142
(20.063.1). (C) Plasmodium parasite rates in Mossi (solid line) and Fulani
(dotted line) in the seven different surveys. More than 95% of infections
were due to P. falciparum. Bars denote the 95% CI. Numbers of
individuals and average age as in B.
doi:10.1371/journal.pone.0017980.g005
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was statistically significant (Table S1). A parallel trend was
observed when the seroprevalence was analyzed, as shown by
the independent analysis of the seven different surveys, both in the
Mossi and in the Fulani (Figure 6B, coloured thin line). The
frequency of responders was higher in children aged 1–10 years
than in adults (.20 years old) in 13 out of 14 cases and the
difference was in most cases statistically significant (10/14, Table
S1). A cumulative trend, which may help overcoming possible bias
due to the small size of some samples, was obtained pooling
together the data of all the surveys, (Figure 6B, black tick line).
Overall these observations clearly show that the anti-gSG6 IgG
response decreased in exposed individuals after approximately ten
years of age; this decrease was more evident in the Fulani, who
exhibit higher antibody levels and higher seroprevalence,
especially in young children.
Discussion
With almost 250 million cases and roughly a million deaths
among children (WHO 2008, http://www.who.int/malaria/en/)
malaria is still a devastating disease, especially in sub-Saharan
Africa where P. falciparum and An. gambiae, the most deadly
parasite-vector combination, are widely spread. The assessment of
transmission intensity, the determination of spatial and seasonal
variation of mosquito density and the evaluation of both vector
and parasite control interventions are of paramount importance
for the implementation of effective malaria control programs. The
gold standard classical method for the assessment of malaria
transmission intensity is the determination of the entomological
inoculation rate (EIR), which measures human exposure to
parasite-carrying mosquitoes. However, entomological measures
are labor-intensive, expensive and may be difficult to apply (i.e.
when mosquito numbers are low) or face logistic constraints.
Alternative methods to estimate Anopheles density would be
extremely valuable, allowing for epidemiological studies also when
the use of classical entomological methods would be difficult or
impossible. Serological methods to estimate malaria transmission
intensity based on the antibody response to parasite antigens have
been developed or are under current development [27–30] and,
therefore, the parallel measure of the antibody response to
Anopheles salivary antigens would be especially convenient [31].
In addition, the development of serological tools would also allow
for the assessment of Anopheles exposure in children, which is
ethically unfeasible by human landing catches, the method
traditionally used with adult volunteers. Moreover, the malaria
burden is currently undergoing a phase of decline in several areas
of sub-Saharan Africa [32], most likely because of the improved
prevention, diagnosis and treatment following the increased
financial support of the last few years (i.e. enhanced availability
of insecticide-treated-bednets and/or of artemisinin combination
therapies). The availability of serological markers of exposure to
Anopheles bites would represent a further complementary tool
especially in low malaria transmission areas and for the monitoring
of control interventions based on anti-vector measures.
The correlation of anti-saliva antibody response to Anopheles
density and disease risk has been previously reported [10–13],
although further evaluation and development of the methodology
has been limited by the difficulty of obtaining immunogenic
recombinant salivary proteins in large amounts. The availability of
large amount of information from the salivary transcriptomes of
mosquitoes and other blood feeding arthropods [3,19] is offering
new opportunities for the development of recombinant salivary
proteins as epidemiological markers of exposure to disease vectors,
as recently shown for the sand fly Lutzomyia longipalpis, a vector of
the Leishmania parasite [33].
We expressed and purified the anopheline-specific gSG6 and we
report here the first large scale analysis of the humoral response to
a recombinant An. gambiae salivary protein. In our surveys the
entomological data are based on pyrethrum spray catches, a
Figure 6. Anti-gSG6 IgG response by age in the ethnic groups
Mossi and Fulani. (A) Box plot of OD values among responders in the
August ’94 survey (Mossi, empty boxes; Fulani, grey boxes). Age groups
are indicated at the bottom (Mossi: 1–5, n = 20; 5–10, n = 26; 10–20,
n = 32; 20–40, n = 18; .40, n = 9. Fulani: 1–5, n = 19; 5–10, n = 25; 10–20,
n = 32; 20–40, n = 14; .40, n = 4). Box plots, whiskers and p values as in
Figure 4A (*, 0.01,p,0.05). (B) Prevalence of antibodies to gSG6 in
Mossi (top) and Fulani (bottom) in the seven different surveys according
to age (thin coloured lines). A cumulative trend was obtained pooling
together the data of all the surveys (black tick line with 95% CI). The
number of individuals analyzed for each survey are included as
supplementary information (Text S1).
doi:10.1371/journal.pone.0017980.g006
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method that can be less accurate as compared to human landing
catches on adult volunteers. However, even within their possible
lower degree of accuracy, our measurements clearly and reliably
document the sharp decrease in Anopheles density both during the
dry season (March ‘95) and after application of ITC (July-October
‘96). Our study confirms the immunogenicity of the An. gambiae
gSG6 and shows the absence of significant cross-reactivity to other
widespread antigens. Moreover, the recombinant protein appears
at least three to fivefold more sensitive than the gSG6-P1 peptide
used in previous studies [22,23], as indicated both by our
comparative tests (not shown) and by the different serum dilutions
needed to work with the peptide and with the recombinant protein
(1:20 and 1:100, respectively).
Both the anti-gSG6 IgG levels and the seroprevalence increased
with the progression of the rain-driven malaria transmission
(August to October ‘94), a pattern that is fully in agreement with
the persistent exposure to Anopheles bites. The response dropped
during the following dry season (March ‘95), when the mosquito
density becomes very low, to increase again during the following
transmission/rainy season (August and October ‘95). These
observations show that the antibody response to the gSG6 protein
exhibits two important features that a potential marker should
possess: (i) it is sensitive to the seasonal variation of human
exposure to mosquito bites, and (ii) decreases significantly after a
few months of reduced or absent exposure, although the main-
tainance of relatively high anti-gSG6 IgG levels and prevalence
was recorded during the dry season in March ‘95. Both the
dynamics of the anti-gSG6 IgG response, which may require a
longer period to vanish, and the specific individual response may
contribute to this maintainance. However, the decrease during the
dry season was statistically significant, suggesting that the immune
response to the gSG6 protein may be sensitive enough to evaluate
variation in vector density. Similar seasonal fluctuations of the
antibody response to An. gambiae saliva have been recently reported
in an epidemiological study in Angola [34]; moreover, a drop in
the anti-saliva IgG response has been previously described in a
cohort of French soldiers, three months after their return from a
travel period in tropical Africa [12]. Therefore, importantly, the
overall pattern of the anti-gSG6 IgG response appears to
accurately reproduce the humoral response to whole saliva. In
addition, this study sets some principles that encourage the search
for additional immunogenic Anopheles-specific salivary proteins,
which may exhibit more suitable and/or desirable properties.
The higher anti-gSG6 IgG response observed in the Fulani as
compared to the Mossi was not unexpected since this ethnic group
was previously found to exhibit a more powerful humoral response
to P. falciparum antigens [24] as well as to other pathogens (D.M.,
unpublished observations). This feature was more recently
suggested to be a consequence of a functional deficit of T
regulatory cells [35]. Importantly, individuals of the Mossi ethnic
group showed a significant variation of the anti-gSG6 antibody
response both during the progression of the transmission/rainy
season and in the transitions rainy-dry and dry-rainy periods. On
the contrary, Fulani appeared to keep a higher humoral response
over time and, for this reason, the seasonal variations of the anti-
gSG6 IgG response were less pronounced than in the Mossi and
did not reach statistical significance. It is known that malaria
infection might negatively affects immune responses and, for this
reason, it may be argued that the different malaria status between
the two groups, Mossi and Fulani, may be responsible of the
differential anti-gSG6 IgG response reported here. However, the
contribution of the different malaria status, if any, must be
negligible because the prevalence of responders to gSG6 in the
different age classes does not show any significant variation
between infected and non-infected individuals in both ethnic
groups (Figure 7). These observations suggest that the human
genetic background should be taken into account to achieve higher
sensitivity while evaluating vector exposure through the antibody
response to saliva or salivary antigens.
In our study area the application of ITC strongly decreased
indoor mosquito density. This reduction appeared to affect the
humoral response to gSG6, as indicated by the absence of any
significant change in prevalence in the period from August to
October ‘96, which is in contrast with the observations concerning
the Mossi during the previous 1994 and 1995 rainy/transmission
seasons (Figure 5A and 5B). However, the impact on both IgG
levels and prevalence is much lower as compared to the dry period
in March ’95, when a similar drop in vector density was reported.
This difference may depend from the selective effect of ITC on
indoor mosquito biting, whereas the outdoor Anopheles biting
activity stayed most likely unchanged during the rainy/transmis-
sion season from July to October ’96. Targeted studies may be
needed to fully address this issue, however, we believe that our
findings and the data recently reported on the IgG specific
response to An. gambiae saliva in Angola [34] support the further
development of arthropod salivary antigens as tools for the
evaluation of the efficacy of vector control interventions by directly
measuring its impact on the population and/or on single
individuals.
Interestingly, the anti-gSG6 IgG response decreased with age, a
pattern that is in contrast with the typical development of the
humoral response to parasite antigens. Relatively poor information
is currently available on the age distribution of the human
humoral response to the An. gambiae saliva or salivary proteins. A
progressive age-dependent decrease of the IgG response to An.
gambiae saliva was previously reported, but this study was limited to
Senegalese children 1 to 5 years old [10]. A similar gradual decline
with age of IgE and IgG against Aedes vexans saliva was found in a
group of Canadian children and blood donors aged from 1 month
to 70 years [36], and this pattern was interpreted as natural
desensitization to mosquito proteins. Human cutaneous reaction
to mosquito bites, as originally described by Mellanby, undergoes
five stages of skin reactivity [37,38]: from initial no reaction of
naı¨ve hosts (stage I), to a delayed-type reaction (II) followed, as
exposure continues, by an immediate- plus delayed-type reaction
(III) and then an immediate response only (IV). Finally, after
Figure 7. Prevalence of anti-gSG6 IgG response in Plamodium
infected and non-infected individuals. Data from the seven
different surveys were pooled together and analyzed according to
ethnic group (Mossi and Fulani), age group (1–10 years, 10–20 years,
.20 years) and malaria infection status (I, infected; NI, non-infected).
doi:10.1371/journal.pone.0017980.g007
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repeated long-term exposure, the host may develop desensitization
and no skin reaction is observed anymore (stage V). Experimental
desensitization to mosquito bites has been observed in a
prospective study on a human subject exposed to bites of Culex
quinquefasciatus and the decline in IgE and IgG responses appeared
correlated to skin desensitization [36,39]. The reduction of the
anti-gSG6 IgG response in adults as compared to children was a
surprising and interesting aspect of our study, which certainly
deserves further investigation. At the moment we can only make
some speculation suggesting that the age-related pattern of the
anti-gSG6 IgG response found in our study may depend from the
continued, intense exposure to bites of anopheline mosquitoes and
may be explained in terms of development of immune tolerance to
insect bite/saliva. However, the immune mechanisms underlying
the development of natural desensitization to mosquito saliva are
not well understood and future, targeted studies, will be necessary
to clarify this aspect and get a deeper understanding of this
phenomenon. In this perspective the An. gambiae gSG6 may
represent an excellent model system to dissect molecular and
cellular events leading to immune tolerance to insect saliva in
humans.
In conclusion this is the first study where a mosquito
recombinant salivary protein is used for a large scale analysis of
the human humoral response in a malaria endemic area. The
gSG6 protein proved to be a sensitive and reliable marker of
human exposure to An. gambiae, suggesting it may be exploited for
the development of risk maps and evaluation of vector control
interventions, although experimental design should take into
proper consideration age and, whenever possible, ethnicity. We
analyzed here the humoral response to gSG6 at a micro-
geographic scale in a condition of high levels of malaria
transmission and vector exposure. It will be important to validate
the gSG6 protein at a macro-geographic level and in conditions of
low transmission/exposure; in this respect the identification and
testing of additional salivary proteins with different immunogenic
properties may prove very useful and, moreover, the use of
combination(s) of antigens may help improving sensitivity. The
availability of a repertoire of An. gambiae recombinant salivary
proteins may also allow for their inclusion in protein microarrays
carrying Plasmodium antigens, which are currently under develop-
ment [40].
The An. gambiae gSG6 used in this study is 98% identical to the
homolog from Anopheles arabiensis (GI: 225572575), a relevant
malaria vector and member of the An. gambiae species complex
[21]. Comparison to the Anopheles funestus protein (GI: 114864550)
shows an identity of approximately 80% [17] and, therefore, it is
reasonable to expect at least a partial cross-recognition by immune
sera of the An. gambiae and the An. funestus proteins. These species
are by far the most important African malaria vectors and,
although this will need further experimental validation, it is likely
that the An. gambiae gSG6 may represent a reliable marker of
exposure to bites of the three main Afrotropical malaria vectors.
While a gSG6 homolog is absent in the South American malaria
vector Anopheles darlingi [15], the Asian mosquito Anopheles stephensi
carries in its saliva a member of the gSG6 protein family [16] and,
therefore, our observations may also be useful for the development
of markers of exposure to Asian malaria vectors.
Finally, the age-related pattern of the anti-gSG6 humoral
response reported here it is unusual and intriguing because the
IgG response was very high in young children and progressively
declined during adult age. The most likely explanation of this
trend is the progressive desensitization to salivary proteins, a
phenomenon that is known to occur after intense and prolonged
exposure to insect bites, as is the case for the population studied
here. The analysis of anti-gSG6 IgG subclasses, and eventually of
IgE, may help better understanding this response pattern.
Presently the knowledge concerning the development of immune
tolerance to insect saliva in humans is still limited and, therefore,
the gSG6 protein may also represent an attractive model system to
get deeper insights into molecular and cellular mechanisms
underlying this phenomenon.
Materials and Methods
Study Area, Subjects and Entomological Observations
Surveys were carried out in the rural villages of Barkoumbilen
and Barkoundouba (,35 km NE of Ouagadougou, Burkina Faso),
inhabited by Mossi, Rimaibe´ and Fulani ethnic groups. As
previously reported [24,25] the area is characterized by intense P.
falciparum transmission particularly during the June–October rainy
season (entomological inoculation rates .100/person/year).
Malaria prevalence is very high, P. falciparum representing about
95% of malaria infections. During the high transmission season, P.
falciparum infection rates range (according to age group) from 60%
to 90% in the Mossi-Rimaibe´ group, and from 20% to 80%
amongst Fulani. Lower prevalences are observed during the dry
low transmission season ranging between 40% and 80% amongst
Mossi and Rimaibe´ and between 0% and 60% in Fulani. The
study protocol was approved by the Technical Committee of the
Centre National de Lutte contre le Paludisme of the Ministry of
Health of Burkina Faso. Oral informed consent for multiple
immuno-parasitological, clinical and entomological surveys was
obtained from a Fulani community living in the village of
Barkoundouba and from a Mossi community living 5 km apart
in the village of Barkoumbilen. A total of 2066 sera collected
during seven surveys in three consecutive years (August ’94,
October ’94, March ’95, August ’95, October ’95, August ’96,
October ’96) were analyzed in this study. Samples size and average
age for each survey can be found in the legends to Figures. Sera
from 60 Roman citizens (1–77 years old) who went to a city
hospital for routine blood tests were used as a control.
Entomological measures were based on indoor pyrethrum spray
catches carried out monthly between August and November ‘94,
in March ‘95, and between July and October ‘95 and ‘96. The
main malaria vectors in the study area were An. gambiae, An.
arabiensis and An. funestus; the latter represented,5% in most cases,
reaching a maximum of ,18% only in October-November ‘94.
Permethrin-impregnated-curtains were installed in the two villages
before the beginning of the high malaria transmission season,
between the June 17 and 20, 1996. Additional details on study site
and on entomological and parasitological aspects has been
previously reported and can be found elsewhere [24–26].
Protein Expression and Purification
The An. gambiae gSG6 was expressed as N-terminal His-tagged
recombinant protein in the E. coli vector pET28b(+) (Novagen).
Briefly, the region encoding the mature An. gambiae gSG6 protein
was PCR amplified using the pPICZaA-G6 plasmid as template
[21], a proofreading DNA polymerase (Pfx, Invitrogen) and the
oligonucleotide primers G6F-Nde (59-GTCTCATATGGAAAA-
GGTGTGGGTCGACCG-39OH) and G6R-Eco (59-GTCTGAA-
TTCAATTACTGCTCCAGGAAGGCCTG-39OH). Directional
cloning in the NdeI/EcoRI-digested pET28b vector yielded the pET-
gSG6 expression vector, that was sequenced and then introduced
into competent BL21(DE3)RIL E. coli cells (Stratagene). After over
night growth (37uC, LB medium) 5 ml of the saturated culture were
transferred into 500 ml of LB and grown up to 0.8 OD600 before
starting induction by IPTG (0.5 mM). After 3 hours cells were
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harvested and the pellet resuspended in 30 ml of 50 mM Tris-HCl
pH 8.0, 50 mg/ml lysozyme and sonicated. Inclusion bodies (IB)
were collected by centrifugation (13000 g, 20 min, 4uC), resus-
pended in extraction buffer (50 mM Tris-HCl pH 8.0, 2 M Urea,
5 mM EDTA, 1% Triton-X100), washed twice (50 mM Tris-HCl
pH 8.0, 2 M Urea) and centrifuged as above. Proteins from IB were
solubilized over-night (20 ml of 20 mM Na2HPO4, 6 M Guani-
dine-HCl, 0.5 M NaCl, 5 mM Imidazole, pH 7.4), centrifuged
(20000 g, 30 min, 4uC) and subjected to affinity chromatography
under denaturing conditions (HisTrap, GE Healthcare) according
to manufacturer instructions. Fractions containing the His-tagged
gSG6 were pooled, concentrated by AmiconH Ultra (Millipore,
10 kDa cut-off), refolded by dilution drop-by-drop in 20 volumes of
refolding buffer (100 mM Tris-HCl pH 8.0, 500 mM L-Arg,
300 mM NaCl, 5 mM L-Glutathione reduced, 0.5 mM L-Gluta-
thione oxidized) and left for an additional 24 to 48 h at 4uC with low
stirring. After centrifugation (20000 g, 30 min, 4uC) the refolded
proteins were concentrated by ultra-filtration (Ultracell 400,
BioMax 10, Millipore), dialyzed against 20 mM Tris-HCl pH 7.5
and further purified by anion exchange chromatography (Hi-
TrapQ, GE Healthcare). Elution was carried out with a linear
gradient 0–0.5 M NaCl in 20 column volumes. Fractions containing
the gSG6 recombinant protein were identified by SDS-PAGE,
pooled, dyalized against 40 mM Tris-HCl pH 7.5 and quantified
by the Bradford Protein Assay (Bio-Rad Laboratories). Homoge-
neity of the purified protein was assessed by silver staining and
further confirmed by RP-HPLC and mass spectrometry (CEINGE
Biotecnologie Avanzate, Naples, Italy). The typical yield of purified
protein was of approximately 9–12 mg/l.
Enzyme-Linked ImmunoSorbent Assay
ELISA was performed according to standard procedures.
Maxisorp 96-well plates (Nunc M9410) were coated overnight
(4uC, 10 mg/ml gSG6 in 15 mM Na2CO3, 35 mM NaHCO3,
3 mM NaN3, pH 9.6). After four washings wells were blocked
(3 hrs, RT) in 150 ml of 1% w/v skimmed dry milk in PBST (PBS
Sigma P4417+0.05% Tween 20), washed again and incubated
overnight at 4uC with 50 ml of serum (1:100) in blocking buffer.
Serum samples were analyzed in duplicate with the antigen and
once without antigen (coating buffer only). After washings plates
were incubated (3 hrs, RT) with 100 ml of polyclonal rabbit anti-
human IgG/HRP antibody (Dako P0214, 1:5000 in blocking
buffer). After washing as above the colorimetric development was
carried out (15 min, RT in the dark) with 100 ml of o-
phenylenediamine dihydrochloride (OPD, Sigma P8287). The
reaction was terminated adding 25 ml of 2 M H2SO4 and the
OD492 was determined using a microplate reader. IgG levels were
expressed as final OD calculated for each serum as the mean OD
value with antigen minus the OD value without antigen. Intra and
inter assay variation of standard samples was below 20%. Sera
whose duplicates showed a coefficient of variation (CV) $20%
were not included in the analysis. The mean OD of unexposed
controls plus 3 SD was used as cut-off value for seropositivity. A
total of 2066 sera from exposed individuals and 60 from
unexposed controls were analyzed by ELISA.
Data Analysis
Anti-gSG6 IgG levels among two independent groups were
compared by the Mann-Whitney U test. Multiple comparisons
were performed by the Kruskal–Wallis test with the Dunn’s post
test correction for comparisons of pair of groups. The Wilcoxon
matched-pairs test was used for comparison of two paired groups.
Frequencies were compared by the chi-square test. All statistical
analysis was performed using GraphPad Prism 5.0H statistical
software (GraphPad Software Inc., La Jolla, CA).
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